WILLIAM COLOMB: Open Payments
NPI 1235279167 · MANDEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$22,257 in 62 payments from 5 companies in 2025. Trend: 2023 $22,357 · 2024 $33,663 · 2025 $22,257
Honoraria: $19,150Travel & lodging: $1,671Food & beverage: $1,436
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 35 | $21,668 |
| ABBVIE INC. | 13 | $262 |
| Noven Therapeutics, LLC | 12 | $178 |
| Alkermes, Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
Products named: Qelbree, VRAYLAR, Xelstrym, LYBALVI, TRINTELLIX.
Industry payments across LA — which companies pay providers there.
